<b>5．The Utilization of Database Research for Japanese HTA from the Perspective of Pharmaceutical </b><b>Industory </b>

DOI Web Site Web Site 3 References
  • HIROI Shinzo
    Japan Medical Affairs, Takeda Pharmaceutical Company Limited
  • YOSHIDA Manami
    Japan Medical Affairs, Takeda Pharmaceutical Company Limited

Bibliographic Information

Other Title
  • <b>5．データベース研究の医療技術評価への利活用</b>　<b>―企業の立場から―</b>
  • データベース研究の医療技術評価への利活用 : 企業の立場から
  • データベース ケンキュウ ノ イリョウ ギジュツ ヒョウカ エ ノ リ カツヨウ : キギョウ ノ タチバ カラ

Search this article

Abstract

<p>A pilot program of cost effectiveness evaluation of pharmaceuticals and medical devices was started in 2016 in Japan. Some values necessary for the evaluation, such as the number of patients, treatment pattern, medical costs, and prevalence of adverse events, can be determined based on analysis of medical databases. The databases used for health economics and outcomes research in Japan are divided into insurance claims databases and hospital-based databases. From the perspective of the pharmaceutical industry, private medical databases, such as Japan Medical Data Center (JMDC) and Medical Data Vision (MDV), which are insurance claims and hospital-based databases, respectively, are easily accessed. When using these databases, it is important to understand the advantages and disadvantages of each. Public databases such as the National Database and MID-NET are expected to resolve the limitations of the databases above. However, they still have issues related to sufficiency of data, generalizability of results, and user access. For the purpose of analysis for future formal programs of cost effectiveness evaluation of pharmaceuticals and medical devices in Japan, improved quality and general use of these databases are desired. Pharmaceutical companies use the medical databases in various departments depending on the purposes. It is urgently required that pharmaceutical companies establish career development plans for the people in charge of cost effectiveness evaluation, to ensure their capability of keeping up to date with the characteristics of the latest medical databases and performing reasonable analysis based on them.</p><p></p>

Journal

References(3)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top